Evidence map›Paper›PMID 36474094›Full record

ArticleAnnals of surgical oncology2023

Complications, Costs, and Healthcare Resource Utilization After Staged, Delayed, and Immediate Free-Flap Breast Reconstruction: A Longitudinal, Claims-Based Analysis.

Ronnie L Shammas, Alexander Gordee, Hui-Jie Lee, Amanda R Sergesketter, Charles D Scales, Scott T Hollenbeck, Brett T Phillips

Open access · bronzeAbstract read
In one paragraph

Article in Annals of surgical oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 3 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 3 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Review
  5. Article
  6. Economic value of ribociclib in early breast cancer in the United States.Journal of managed care & specialty pharmacy · 2026
    Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ronnie L ShammasDivision of Plastic and Reconstructive Surgery, Duke University Medical Center, Durham, NC, USA.ORCID http://orcid.org/0000-0001-5468-8646
Alexander GordeeDepartment of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA.
Hui-Jie LeeDepartment of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA.
Amanda R SergesketterDivision of Plastic and Reconstructive Surgery, Duke University Medical Center, Durham, NC, USA.
Charles D ScalesDivision of Urologic Surgery, Duke University Medical Center, Durham, NC, USA.
Scott T HollenbeckDivision of Plastic and Reconstructive Surgery, Duke University Medical Center, Durham, NC, USA.
Brett T PhillipsDivision of Plastic and Reconstructive Surgery, Duke University Medical Center, Durham, NC, USA. brett.phillips@duke.edu.
Duke Medical Center · USDuke University · US

Funding

Support for QA/QC for Prior Approval ProcessUL1TR002553 · NCATS · DUKE UNIVERSITY · PI LI, JENNIFER S, MCNAMARA, JAMES O. · 2018 to 2023
$58.5M
NCATS NIH HHS CTSA Grant (UL1TR002553)NCATS NIH HHS UL1 TR002553
6 · The paper itself

Abstract

backgroundThere is a lack of consensus detailing the optimal approach to free-flap breast reconstruction when considering immediate, delayed, or staged techniques. This study compared costs, complications, and healthcare resource utilization (HCRU) across staged, delayed, and immediate free-flap breast reconstruction. PATIENTS AND

methodsRetrospective study using MarketScan databases to identify women who underwent mastectomies and free-flap reconstructions between 2014 and 2018. Complications, costs, and HCRU [readmission, reoperation, emergency department (ED) visits] occurring 90 days after mastectomy and 90 days after free flap were compared across immediate, delayed, and staged reconstruction.

resultsOf 3310 women identified, 69.8% underwent immediate, 11.7% underwent delayed, and 18.5% underwent staged free-flap reconstruction. Staged reconstruction was associated with the highest rate (57.8% staged, 42.3% delayed, 32.0% immediate; p < 0.001) and adjusted relative risk [67% higher than immediate (95% CI: 49-87%; p < 0.001)] of surgical complications. Staged displayed the highest HCRU (staged 47.9%, delayed, 38.4%, immediate 25.2%; p < 0.001), with 16.5%, 30.7%, and 26.5% of staged patients experiencing readmission, reoperation, or ED visit, respectively. The adjusted probability of HCRU was 206% higher (95% CI: 156-266%; p < 0.001) for staged compared with immediate. Staged had the highest mean total cost (staged $106,443, delayed $80,667, immediate $76,756; p < 0.001) with regression demonstrating the adjusted mean cost for staged is 31% higher (95% CI: 23-39%; p < 0.001) when compared with immediate.

conclusionsStaged free-flap reconstruction is associated with increased complications, costs, and HCRU, while immediate demonstrated the lowest. The potential esthetic benefits of a staged approach should be balanced with the increased risk for adverse events after surgery.

Indexed as

Breast NeoplasmsFree Tissue FlapsMammaplastyFemaleHumansMastectomyPatient Acceptance of Health CarePostoperative ComplicationsRetrospective Studies

Identifiers

PMID36474094
PMCPMC9735033
OpenAlexW4311286064

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.